National Institute Of Cardiovascular Diseases, Pakistan
Clinical trials sponsored by National Institute Of Cardiovascular Diseases, Pakistan, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a special diet before heart surgery cut the need for blood transfusions? Results expected May 2027 (estimated)
- Heart failure drug aims to boost daily living and cut hospital visits Results expected May 2027 (estimated)
- Heart rate drug may speed recovery from shock after heart attack Results expected May 2027 (estimated)
-
Can a special diet before heart surgery cut the need for blood transfusions?
Disease control Not yet recruitingThis trial tests whether a nutrition program before elective open-heart surgery can reduce blood transfusions in patients with mild anemia. Participants receive a high-protein diet with iron and vitamin supplements, plus educational materials, for 8 to 12 weeks before their opera…
Phase 3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Heart failure drug aims to boost daily living and cut hospital visits
Disease control Not yet recruitingThis trial investigates whether vericiguat, added to standard treatment, can improve quality of life and reduce hospitalizations in adults with heart failure and reduced ejection fraction. Participants receive either vericiguat or a placebo for six months, and their health status…
Phase 4 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC